Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NVIDIA
NVDA
5
Broadcom
AVGO
US Stock MarketDetailed Quotes
GlaxoSmithKline (GSK)
- 49.120
- -1.670-3.29%
Close Jan 15 16:00 ET
- 49.500
- +0.380+0.77%
Post 20:01 ET
100.09BMarket Cap13.80P/E (TTM)
50.500High49.070Low6.55MVolume50.480Open50.790Prev Close323.42MTurnover0.33%Turnover Ratio29.50P/E (Static)2.04BShares51.46052wk High4.63P/B96.54BFloat Cap31.37052wk Low1.70Dividend TTM1.97BShs Float51.460Historical High3.45%Div Yield TTM2.82%Range %6.114Historical Low49.413Avg Price1Lot Size
GlaxoSmithKline (GSK) Key Financial Indicators
GSK Earnings per Share (EPS)
According to the latest financial report of GlaxoSmithKline, the latest earnings per share (TTM) for the company is 0.98. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: GBP
Quarterly
Loading...
GSK Free Cash Flow (FCF)
Interested in knowing about GlaxoSmithKline's free cash flow? The latest report shows it as 1.34B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: GBP
Quarterly
Loading...
GSK Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of GlaxoSmithKline shows that the company's current ratio is 0.84, indicating healthy liquidity.
Currency: GBP
Quarterly
Loading...
GSK Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of GlaxoSmithKline, the quick ratio is 0.53, indicating that the company can meet its short-term debt obligations.
Currency: GBP
Quarterly
Loading...
GSK Return on Equity (ROE)
Want to learn more about the financial health of GlaxoSmithKline? The latest ROE figure is 13.01%, indicating that the company has stable profitability.
Currency: GBP
Quarterly
Loading...
GSK Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of GlaxoSmithKline, the total asset return on investment (ROA) is 3.34%.
Currency: GBP
Quarterly
Loading...
GSK Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check GlaxoSmithKline's latest financial report to see how their gross margin is doing - currently at 73.58%.
Currency: GBP
Quarterly
Loading...
GSK Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of GlaxoSmithKline, the net profit margin is 25.08%, which is a good sign for its profitability.
Currency: GBP
Quarterly
Loading...
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?